5-APB-NBOMe, also known as N-(2-methoxybenzyl)-5-(2-aminopropyl)benzofuran, is a drug of the phenethylamine, amphetamine, benzofuran, and 25-NB (NBOMe) families related to the entactogen and mildly psychedelic drug 5-APB. It is the N-(2-methoxybenzyl) derivative of 5-APB. The preclinical pharmacokinetics of 5-APB-NBOMe have been studied. The drug was encountered as a novel designer drug in Germany in 2014.

See also

External links